When using GlyRS-IN-1 to induce diabetic mouse model for a long time, if gavage is used (8 weeks, 3 times a week), is there a recommended dosage range?
Background supplement:
Recently, attempts have been made to establish a diabetic model by targeting the GlyRS pathway. Preliminary preliminary experiments have found that different doses of GlyRS-IN-1 (0.5-2 mg/kg) can affect blood glucose levels after short-term administration, but there are differences in long-term toxicity and model stability. Considering the relationship between gavage frequency and metabolic accumulation, I hope to know whether there is a dosage regimen supported by literature or experience, especially in combination with specific data of mouse strains (such as C57BL/6).
Looking forward to sharing guidance!
[Questions are selected from MedChemExpress (MCE) customer consultation emails.]